MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directoryClinical decision support software from GenXys that uses pharmacogenomic and medication data to support personalized medication decisions in clinical workflows.
Organizations implementing pharmacogenomics or precision prescribing inside EHR, EMR, pharmacy management, or medication therapy management workflows.
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating GenXys TreatGx as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as pharmacogenomic clinical decision support and verify local CDS, laboratory, privacy, and prescribing obligations for the intended use and jurisdiction. |
|---|---|
| Privacy | Review genomic, medication, condition, allergy, EHR, pharmacy, lab, and user-action data flows plus BAA terms, hosting, access, retention, and auditability. |
| Evidence | Validate source-guideline currency, PGx phenotype handling, interaction prioritization, condition coverage, alert burden, and recommendation acceptance in local pilots. |
| Workflow | Best governed through prescriber, pharmacist, informatics, lab, and precision medicine review with explicit responsibility for final prescribing decisions. |
GenXys describes TreatGx as clinical decision support software for precision prescribing that integrates pharmacogenomic data with patient health records and uses evidence-based algorithms, CPIC, PharmGKB, FDA pharmacogenomic markers, drug interaction data, side-effect sorting, and EHR/EMR or pharmacy management system integration.
Not for: Automated prescribing, raw genetic test interpretation without validated inputs, or medication changes without clinician and pharmacist review.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.